Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | 2,458 | N/A | N/A |
| Depreciation Amortization | 1,823 | N/A | N/A |
| Accounts receivable | -9,263 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,183 | N/A | N/A |
| Other Working Capital | 62,159 | N/A | N/A |
| Other Operating Activity | -3,916 | 0 | 0 |
| Operating Cash Flow | $55,444 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -411 | N/A | N/A |
| Net Acquisitions | 671 | N/A | N/A |
| Purchase Sale Intangibles | -9 | N/A | N/A |
| Other Investing Activity | -2,058 | 0 | 0 |
| Investing Cash Flow | $-1,798 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -1,371 | N/A | N/A |
| Common Stock Issued | 79,519 | N/A | N/A |
| Other Financing Activity | -1,205 | 0 | 0 |
| Financing Cash Flow | $76,943 | $N/A | $N/A |
| Exchange Rate Effect | 8,652 | N/A | N/A |
| Beginning Cash Position | 10,044 | N/A | N/A |
| End Cash Position | 149,287 | N/A | N/A |
| Net Cash Flow | $139,242 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 55,444 | N/A | N/A |
| Capital Expenditure | -461 | N/A | N/A |
| Free Cash Flow | 54,983 | 0 | 0 |